Posts

Showing posts from June, 2023

Optic Neuritis Market Industry Insights, Trends, and Forecasts to 2027

Image
  Optic neuritis market is expected to gain market growth at a healthy CAGR 5.60% in the forecast period of 2027.  Industry Analysis Optic neuritis is characterised as a swelling or inflammation that occurs in the optic nerve. It is also commonly termed as optic papillitis and retro tubular neuritis. The optic nerves is a nerve fibres that has the capability of transmits visual information from eye to brain. The inflammation usually leads to damage in the optic nerve and temporary vision loss in only one eye typically. Pediatric optic neuritis and adult optic neuritis and are two types which is based on the age group of patients diagnosed with optic neuritis. The common way to diagnose the optic neuritis is physical exam, and medical history. The treatment becomes essential at early stage possible due to life risk of losing human eye vision in this disorder. The most common symptoms associated with optic neuritis include pain with eye movement...

Brain Cancer Diagnostic Market Industry Insights, Trends, and Forecasts to 2030

Image
  The Global Brain Cancer Diagnostic Market is expected to gain market growth in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 18.9% in the forecast period of 2023 to 2030 and is expected to reach USD 6,977.02 million by 2030. Industry Analysis One of the primary factors driving the growth of the brain cancer diagnostic market is the rising cases of brain cancer worldwide. The continuing clinical trial research being conducted by several companies for better treatment leads to market expansion. The market is also influenced by rising awareness of the early diagnosis of brain cancer and innovations in drug delivery to brain cancer cells. However, the high cost associated with diagnosis & treatment for brain cancer, late diagnosis of brain cancer resulting in poor prognosis, and side-effects of treatment drugs & therapies acts as a restraining factor for the global brain cancer diagnostic market in...